health π New drugs changing the game in weight loss treatment
GLP-1 receptor agonists are emerging as significant tools in managing obesity, a complex chronic disease. These medications, initially for type 2 diabetes, mimic natural hormones to increase fullness and reduce food intake. Semaglutide showed about 15% average weight loss over 68 weeks, while tirzepatide reached 20% or more in trials. These drugs offer benefits like improved blood glucose and cardiovascular outcomes beyond just weight loss. However, they must be used alongside lifestyle changes, as stopping treatment can cause weight regain.